跳至主要内容
临床试验/IRCT201310083210N5
IRCT201310083210N5已完成3 期

Study of the effect of Memantine on negative symptoms and inflammatory biomarkers (IL6, TNFa CRP) in patients with schizophrenia or schizoaffective disorders

Faculty of pharmacy, Shahid Beheshti University of Medical Scienses0 个研究点目标入组 59 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
59

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 65 years(—)
性别
All

入选标准

  • patients aged 18-65 years old; patients that base on DSM V criteria has diagnosis of schizophrenia or schizoaffective disorder; patients who stable on medication four weeks prior to baseline and has not planned medication change.
  • Exclusion criteria: subject that organic brain disease or neurological diagnosis (including neurological disorder or an active seizure); subjects who will meet the criteria for DSM-V diagnosis of alcohol or substance dependence within the last six month; any change of psychotropic medication within the previous four weeks.

排除标准

  • 未提供

研究者

发起方
Faculty of pharmacy, Shahid Beheshti University of Medical Scienses

相似试验